Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Anti-idiotypic
Patent
1979-10-02
1981-11-24
Sneed, Helen M. S.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Anti-idiotypic
423409, 260429R, A01N 1100, C01F 1500
Patent
active
043024467
ABSTRACT:
A stable, microcrystalline form of cisplatin, a process for its preparation, and stable, sterile dry-mix formulations thereof which are more rapidly reconstituted with sterile water to produce solutions suitable for intravenous administration to man than are similar formulations containing "regular" cisplatin. The microcrystalline cisplatin and dry-mix formulations thereof are prepared without the use of lyophilization.
REFERENCES:
Greene et al., American Journal of Hospital Pharmacy 36, 38-43, (1979).
Rozencweig et al., Annals of Internal Medicine, 86, 803-812, (1977).
Talley et al., Cancer Chemotherapy Reports, 57, 465-471, (1973).
Rossof et al., Cancer, 30 1451-1456, (1972).
Rosenberg et al., Nature 205 698-699, (1965).
Rosenberg et al., Nature 222 385-386, (1966).
Handelsman et al., Clinical Brochure, Cis Platinum (II), Diamminedichlori de National Cancer Inst., pp. 31 & 32, (1974).
Granatek Alphonse P.
Kaplan Murray A.
Bristol-Myers Company
Lloyd Richard R.
Sneed Helen M. S.
LandOfFree
Pharmaceutical compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2174708